MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Depression

Selected References:

  • Anderson CA, Lieser C. 2015. Prenatal depression: Early intervention. Nurse Pract; 40(7):38-46.
  • Bennett HA, et al. 2004. Depression during Pregnancy. Clin Drug Invest; 24 (3): 157-179.
  • Bennett HA, et al. 2004. Prevalence of Depression during Pregnancy: Systematic Review. Obstet Gynecol; 103: 698-709
  • Berard A, et al. 2017. Antidepressant use during pregnancy and the risk of major congenital malformation in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open 7:e013372.
  • Bonari L et al. 2004. Perinatal Risks of Untreated Depression during Pregnancy. Can J Psychiatry; 49:726-735.
  • Burt VK & Stein K. 2002. Epidemiology of Depression throughout the female life cycle. J Clin Psych; 63 (suppl 7): 9-15.
  • Centers for Disease Control and Prevention. 2018. Depression Among Women of Reproductive Age: https://www.cdc.gov/reproductivehealth/Depression/
  • Chisolm MS, Payne JL. 2016. Management of psychotropic drugs during pregnancy. BMJ; 532:h5918.
  • Chan J, et al. 2014. Risks of untreated depression in pregnancy. Can Fam Physician. 60(3):242-3.
  • Coburn SS, et al. 2018. Prenatal Maternal Depressive Symptoms Predict Early Infant Health Concerns. Matern Child Health J; 22(6):786-793.
  • Cohen LS, et al. 2006. Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment. JAMA; 295: 499-507.
  • Committee on Obstetric Practice. 2015. The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression. Obstet Gynecol; 125(5):1268-71.
  • Dalke KB, et al. 2016. Depression and Anxiety during Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making. Curr Psychiatry Rep; 18(6):59.
  • Dias CC, et al. 2015. Breastfeeding and Depression. A systematic review of the literature. J Affect Disord; 171:142-54.
  • Einarson A. 2005. The Safety of Psychotropic Drug Use during Pregnancy. Medscape General Medicine; 7 (4): 3.
  • Evans-Hoeker et al. 2018. Major depression, antidepressant use and male and female fertility. Fertility and Sterility Vol 109 Issue 5, pp 879-887.
  • Galbally M, et al. 2017. Neonatal adaption following intrauterine antidepressant exposure: assessment, drug assay levels, and infant development outcomes. Ped Res; 82(5): 806-813.
  • Gavin NI, et al. 2005. Perinatal Depression: A Systematic Review of Prevalence and Incidence. Obstet Gynecol; 106 (5 pt 1): 1071-83.
  • Glasser S, Lerner-Geva L. 2018. Focus on fathers: paternal depression in the perinatal period. Perspect Public Health. 2018 Jul 25:1757913918790597. doi: 10.1177/1757913918790597. [Epub ahead of print]
  • Gustafsson HC, et al. 2018. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised. Dev Psychopathol. 2018 Aug;30(3):773-785.
  • Hahn-Holbrook J, et al. 2013. Does Breastfeeding Offer Protection Against Maternal Depressive Symptomology? Arch Women’s Ment Health; 16:411-422.
  • Jablensky AV, et al. 2005. Pregnancy, Delivery, and Neonatal Complications in a Population Cohort of Women with Schizophrenia and Major Affective Disorders. Am J Psychiatry; 162: 79-91.
  • Jiang W, et al. 2018. The relationship of dietary diversity score with depression and anxiety among prenatal and post-partum women. J Obstet Gynaecol Res. doi: 10.1111/jog.13728. [Epub ahead of print]
  • Kelly RH, et al. 2002. Psychiatric and Substance Use Disorders as Risk factors for low birth weight and Preterm Delivery. Obstet Gynecol; 100 (2): 297-304.
  • Kurki T, et al. 2000. Depression and Anxiety in Early Pregnancy and Risk for Pre-eclampsia. Obstet Gynecol; 95 (4): 487-490.
  • McLearn KT, et al. 2006. Maternal Depressive Symptoms at 2 to 4 Months Post-Partum and Early Parenting Practices. Arch Pediatr Adolesc Med; 160: 279-284.
  • Muzik M, Hamilton SE. 2016. Use of Antidepressants during Pregnancy? What to Consider when Weighing Treatment with Antidepressants against Untreated Depression. Matern Child Health J.
  • Nillni YI, Wesselink AK, Gradus JL, et al. 2016. Depression, anxiety, and psychotropic medication use and fecundability. Am J Obstet Gynecol.;215(4):453.e1-453.e4538.
  • Nillni YI, Crowe HM, Yland JJ, Wesselink AK, Wise LA. 2022. The association between time-to-pregnancy and postpartum depressive symptoms in a North American prospective cohort study. Ann Epidemiol.;74:51-57.
  • Okun ML. Disturbed Sleep and Postpartum Depression. Curr Psychiatry Rep; 18(7):66.
  • Ogunyemi D, et al. 2018. The Contribution of Untreated and Treated Anxiety and Depression to Prenatal, Intrapartum, and Neonatal Outcomes. AJP Rep; 8(3):e146-e157.
  • Pajulo M, et al. 2001. Antenatal Depression, Substance Dependency and Social Support. J Aff Disorders; 65:9-17.
  • Robertson E, et al. 2004. Antenatal Risk Factors for Postpartum Depression: A Synthesis of Recent Literature. Gen Hosp Psychiatry; 26 (4): 289-95.
  • Romero-Gonzalez B, et al. 2018. Newborn infants’ hair cortisol levels reflect chronic maternal stress during pregnancy. PLoS One; 13(7):e0200279.
  • Sanz EJ, et al. 2005. Selective Serotonin Reuptake Inhibitors in Pregnant Women and Neonatal Withdrawal Syndrome: A Database Analysis. Lancet; 365: 482-487.
  • Vigod SN, et al. 2016. Depression in pregnancy. BMJ; 352:i1547.
  • Vintzileos AM, et al. 2002. The Impact of Prenatal Care in the United States on Preterm Births in the Presence and Absence of Antenatal High-Risk Conditions. Am J Obstet Gynecol; 187: 1254-1257.
  • Wdowik, A et al 2017. Impact of emotional disorders on semen quality in men treated for infertility. Neuro Endocrin Lett. Feb; 38(1):50-58.
  • Xu F, et al. 2014. Does Infant Feeding Method Impact on Maternal Mental Health? Breastfeeding Medicine; 9(4).

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.